Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Meningococcal B recombinant vaccine

Meningococcal B recombinant vaccine

US Patent 12053516 · Granted Aug 6, 2024

Estimated economic value: $17,149,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Immunogenic compositions against S. aureus2020
Compositions comprising N. meningitidis proteins2019
Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modifi2018
Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modifi2017
Porphyromonas gingivalis polypeptides2016
Porphyromonas gingivalis polypeptides2016
Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modifi2015
Culture medium for Haemophilus influenzae type B2014
Method for the production of overproducing Staphylococcus aureus strains2013
Type 5 and type 8 capsular polysaccharides of overproducing S. aureus strains2012
Nucleic acids and polypeptides specific of the Neisseria genus pathogenic strain2012
Hepatitis C virus vaccine2012